Market-Moving Events

The world's most valuable company has again defied eye-watering forecasts, delivering a bumper set of financial results.

Bitcoin futures soared almost $10,000 ever since President Trump called on Congress to pass the Clarity Act. @CharlesSchwab's Nathan Peterson offers a thorough look into the catalysts backing Bitcoin's price action and the rally across other cryptocurrencies and crypto-tied stocks.

Ankur Crawford, executive vice president at Alger, joins 'Closing Bell' to discuss Nvidia's market activity, the backlash on data centers and more.

U.S. stocks ticked down after surprisingly heated inflation data as traders kept their powder dry ahead of earnings from artificial-intelligence bellwether Nvidia after the bell.

With election day ten weeks away, the stock market is beginning to care about the midterms. Wall Street is preparing for a range of scenarios, from the possibility of contested or delayed election results to the prospect of a divided Congress.

Nuvation Bio Inc. is downgraded to Hold after a >200% share price run, reflecting cautious optimism amid early Ibtrozi launch dynamics. Ibtrozi, now the leading ROS1 TKI in new patient starts, posted $23.2m Q2 revenues with strong first-line uptake, but overall patient starts declined sequentially. NUVB management projects a $3.8bn Ibtrozi peak revenue opportunity, but current sales and analyst estimates suggest a more modest trajectory near $650m.